Comparative Evaluation of Beneficiary Effects of Priming Agents (2% Hydroquinone and 0.025% Retinoic Acid) in the Treatment of Melasma with Glycolic Acid Peels

BACKGROUND Chemical peels have become a popular modality in the treatment of melasma. The most disturbing side effect of this procedure is postinflammatory hyperpigmentation. This may be minimized with the help of priming agents. Because there is a paucity of such studies, this study was taken up to evaluate the beneficial effects of hydroquinone versus tretinoin as priming agents in treatment of melasma with glycolic acid peels. METHODS Sixty patients of melasma were randomly assigned in three groups of 20 patients each in a single-blind study. Group I received only glycolic acid peels while Groups II and III were primed with 0.025% tretinoin and 2% hydroquinone, respectively, for 2 weeks before peeling. The patients received serial glycolic acid peels fortnightly for the first 3 months and then monthly for the next 3 months and were then followed up for the next 3 months when peeling was stopped. Clinical and photographic evaluation was done at 3, 6, and 9 months, and subjective improvement was noted. RESULTS There was an overall decrease in MASI from baseline to 6 months in all three groups but it was highly significant between Groups I and III (p<.001) at 6 and 9 months and significant between Groups II and III (p<.01) at 9 months. CONCLUSIONS Results are better with hydroquinone as priming agent compared to tretinoin in enhancing the results with glycolic acid peels in melasma and in decreasing postpeel postinflammatory hyperpigmentation.

[1]  M. Picardo,et al.  Treatment of melasma. , 2006, Journal of the American Academy of Dermatology.

[2]  C. Grover,et al.  Efficacy of Hydroquinone (2%) Versus Tretinoin (0.025%) as Adjunct Topical Agents for Chemical Peeling in Patients of Melasma , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[3]  B. Rao,et al.  Melasma: A Review , 2004, Journal of cutaneous medicine and surgery.

[4]  P. Puri,et al.  Melasma in Indian males. , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[5]  A. Kanwar,et al.  The Combination of Glycolic Acid Peels With a Topical Regimen in the Treatment of Melasma in Dark‐Skinned Patients: A Comparative Study , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[6]  Bhushan Kumar,et al.  Safety and efficacy of glycolic acid facial peel in Indian women with melasma , 2001, International journal of dermatology.

[7]  A. Pandya,et al.  Disorders of hyperpigmentation. , 2000, Dermatologic clinics.

[8]  P. Grimes The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[9]  T. Piamphongsant Treatment of melasma: a review with personal experience , 1998, International journal of dermatology.

[10]  M. Lawry,et al.  Glycolic Acid Peels for Postinflammatory Hyperpigmentation in Black Patients: A Comparative Study , 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[11]  H. Henderson Manual of chemical peels , 1996 .

[12]  P. Grimes Melasma. Etiologic and therapeutic considerations. , 1995, Archives of dermatology.

[13]  T. Hamilton,et al.  Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. , 1994, Archives of dermatology.